News

DNV publication on AI Medical Device Software under the MDR

Published on: 28/03/2022

DNV publication on AI Medical Device Software under the MDR
AI, AI and data
Member News

AI medical device software has the potential to greatly improve healthcare. This entails the compliance to regulatory requirements to safeguard patient safety and ensure the benefit-risk of new technologies. Read our latest white paper for recommendations regarding automation bias and performance conformity assessment in a changing European regulatory landscape for the medical devices industry.

The digitalization of healthcare generates a massive amount of data that exceeds the analytical capabilities of individual clinicians. Artificial intelligence (AI) has the potential to automate the analysis of these data, carrying the promise of better and more sustainable healthcare. However, doing this requires AI medical device software to be as safe and performant as any other trustworthy medical device.

Significant progress has been made in artificial intelligence (AI) over the past few years. However, substantial work still needs to be done to understand the technical and clinical aspects that make AI software systems different from established medical device software and the impact they have on their regulatory conformity assessment in Europe. Without explicit regulatory guidance, some conformity assessment aspects of AI technologies remain unclear. 

This paper reviews some key aspects of safety and performance assessments of AI medical device software according to the existing regulation (EU) 2017/745 (MDR) ahead of the upcoming regulatory updates and standards publication.

Discover more about DNV:

DNV is an independent foundation with over 150 years of history in assurance and risk management. We use our knowledge to advance safety and performance, set industry benchmarks, and inspire and invent solutions to tackle global transformations. DNV’s Healthcare research programme works with partners through large-scale public-private research and innovation projects (see BigMed, the Nordic Alliance for Clinical Genomics, REALMENT and AI-Mind to name a few) to assess trustworthy AI adoption, enable data sharing opportunities through federated data networks, meet patient autonomy needs with dynamic consent, explore quality driven benchmarking approaches in clinical genomics and assure the safe bringing-to-market of new AI medical device software solutions.

NEWS​

Related News

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Applications Now Open: Spread & Scale Academy

1 Jul 2025
Do you have an innovation or solution that’s working well in one place and could make a difference elsewhere?

Securing funding for your innovation: The bid lifecycle

1 Jul 2025
This blog is the second instalment in our Bid Lifecycle series, where we explore the key stages involved in securing funding for innovative healthcare...

HLTH Brought the Energy to Amsterdam. Now It’s Vegas’ Turn.

26 Jun 2025
Next up: HLTH USA, October 19–22 in Las Vegas.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *